Magnesium isoglycyrrhizinate alleviates alcohol-associated liver disease through targeting HSD11B1
Lu Xiao, Lu Li, Shasha Wu, Zhaodi Che, Yuyang Du, Jingyi Zheng, Jingsong Yan, Hao Wang, Hong Zhang, Yan Li, Jia Xiao
This study identifies HSD11B1 as a direct target of magnesium isoglycyrrhizinate, revealing its therapeutic mechanism in alcohol-associated liver disease through the HSD11B1-SREBP2-IDI1 signaling axis.
eLife · Jul 28, 2026Peer-reviewedPharmacology & Toxicology